Freitas, F. & Attwell, D. Pericyte-mediated constriction of renal capillaries evokes no-reflow and kidney injury following ischaemia. eLife 11, e74211 (2022).
O’Farrell, F. M. & Attwell, D. A role for pericytes in coronary no-reflow. Nat. Rev. Cardiol. 11, 427–432 (2014).
Rezkalla, S. H. & Kloner, R. A. No-reflow phenomenon. Circulation 105, 656–662 (2002).
O’Farrell, F. M. et al. Capillary pericytes mediate coronary no-reflow after myocardial ischaemia. eLife 6, e29280 (2017).
Pénzes, M. et al. Direct myosin-2 inhibition enhances cerebral perfusion resulting in functional improvement after ischemic stroke. Theranostics 10, 5341–5356 (2020).
Kloner, R. A., Ganote, C. E. & Jennings, R. B. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J. Clin. Invest. 54, 1496–1508 (1974).
Lameire, N. H. et al. Acute kidney injury: an increasing global concern. Lancet 382, 170–179 (2013).
Mehta, R. L. et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385, 2616–2643 (2015).
Gibson, C. M. et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101, 125–130 (2000).
Ndrepepa, G. et al. Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors. Clin. Res. Cardiol. 113, 1006–1016 (2024).
Zhang, B. et al. The coronary angiography-derived index of microcirculatory resistance predicts perioperative myocardial injury in stable coronary artery disease patients undergoing PCI. Heliyon 10, e35240 (2024).
Nicolau, A. M. et al. Molecular mechanisms of microvascular obstruction and dysfunction in percutaneous coronary interventions: from pathophysiology to therapeutics—a comprehensive review. Int. J. Mol. Sci. 26, 6835 (2025).
Peppiatt, C. M., Howarth, C., Mobbs, P. & Attwell, D. Bidirectional control of CNS capillary diameter by pericytes. Nature 443, 700–704 (2006).
Yemisci, M. et al. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat. Med. 15, 1031–1037 (2009).
Berthiaume, A.-A., Hartmann, D. A., Majesky, M. W., Bhat, N. R. & Shih, A. Y. Pericyte structural remodeling in cerebrovascular health and homeostasis. Front. Aging Neurosci. 10, 210 (2018).
Erdener, ŞE., Küreli, G. & Dalkara, T. Contractile apparatus in CNS capillary pericytes. Neurophotonics 9, 021904 (2022).
Le, D. E., Zhao, Y. & Kaul, S. Persistent coronary vasomotor tone during myocardial ischemia occurs at the capillary level and may involve pericytes. Front. Cardiovasc. Med. 9, 930492 (2022).
Fu, J., Liang, H., Yuan, P., Wei, Z. & Zhong, P. Brain pericyte biology: from physiopathological mechanisms to potential therapeutic applications in ischemic stroke. Front. Cell. Neurosci. 17, 1267785 (2023).
Fraser, J. F. et al. Intra-arterial verapamil post-thrombectomy is feasible, safe, and neuroprotective in stroke. J. Cereb. Blood Flow Metab. 37, 3531–3543 (2017).
Nazir, S. A. et al. The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of microvascular obstruction during primary percutaneous coronary intervention. Efficacy Mech. Eval. https://doi.org/10.3310/eme03090 (2016).
Hill, R. A. et al. Regional blood flow in the normal and ischemic brain is controlled by arteriolar smooth muscle cell contractility and not by capillary pericytes. Neuron 87, 95–110 (2015).
Hall, C. N. et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508, 55–60 (2014).
Rangaswami, J. et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the american heart association. Circulation 139, e840–e878 (2019).
Mancianti, N., Calatroni, M., Deferrari, G. & La Porta, E. Editorial: kidney and heart cross-talk. Front. Nephrol. 5, 1598135 (2025).
McCullough, P. A. & Ronco, C. Heart-Kidney Cross-Talk. in Critical Care Nephrology Ch. 109, 664–670.e3 https://doi.org/10.1016/B978-0-323-44942-7.00109-6 (Elsevier, 2019).
House, A. A. et al. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 95, 1304–1317 (2019).
Ronco, C., Bellomo, R. & Kellum, J. A. Acute kidney injury. Lancet 394, 1949–1964 (2019).
Annibali, G. et al. “No-reflow” phenomenon: a contemporary review. J. Clin. Med. 11, 2233 (2022).
Wanjare, M., Kusuma, S. & Gerecht, S. Perivascular cells in blood vessel regeneration. Biotechnol. J. 8, 434–447 (2013).
Suthar, S. K. et al. Comprehensive SAR analysis of actomyolytics, drug candidates targeting the actomyosin complex. Eur. J. Med. Chem. 299, 117999 (2025).
Gyimesi, M. et al. Single residue variation in skeletal muscle myosin enables direct and selective drug targeting for spasticity and muscle stiffness. Cell 183, 335–346.e13 (2020).
Straight, A. F. et al. Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science 299, 1743–1747 (2003).
Allingham, J. S., Smith, R. & Rayment, I. The structural basis of blebbistatin inhibition and specificity for myosin II. Nat. Struct. Mol. Biol. 12, 378–379 (2005).
Sirigu, S. et al. Highly selective inhibition of myosin motors provides the basis of potential therapeutic application. Proc. Natl Acad. Sci. USA 113, E7448–E7455 (2016).
Haase, M. et al. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib. Nephrol. 182, 99–116 (2013).
Virzì, G. M. et al. The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1. Cardiorenal Med. 4, 103–112 (2014).
Divakaran, S. & Loscalzo, J. The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics. J. Am. Coll. Cardiol. 70, 2393–2410 (2017).
Aetesam-ur-Rahman, M. et al. Adenosine-induced coronary steal is observed in patients presenting with ST-segment–elevation myocardial infarction. J. Am. Heart Assoc. 10, e019899 (2021).
Juricic, S. et al. Molecular and cellular mechanisms of myocardial ischemia and reperfusion injury: a narrative review. Cells 15, 265 (2026).
Steegh, F. M. E. G. et al. Early loss of peritubular capillaries after kidney transplantation. J. Am. Soc. Nephrol. 22, 1024–1029 (2011).
Ajtai, K., Mayanglambam, A., Wang, Y. & Burghardt, T. P. Human tonic and phasic smooth muscle myosin isoforms are unresponsive to the loop 1 insert. ISRN Struct. Biol. 2013, 634341 (2013).
Gyimesi, M. et al. The mechanism of the reverse recovery step, phosphate release, and actin activation of Dictyostelium myosin II. J. Biol. Chem. 283, 8153–8163 (2008).
Vonrhein, C. et al. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr. D Biol. Crystallogr. 67, 293–302 (2011).
McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296–W303 (2018).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Bricogne G. et al. BUSTER v.2.10.3. https://sbgrid.org/software/titles/buster (Global Phasing, 2018).
Mulvany, M. J. & Halpern, W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41, 19–26 (1977).
Mastitskaya, S., de Freitas, F. S. S., Evans, L. E. & Attwell, D. GLP-1 activates KATP channels in coronary pericytes as the effector of brain-gut-heart signalling mediating cardioprotection. Nat. Commun. 17, 2773 (2026).
Besseling, P. J. et al. A plasma creatinine- and urea-based equation to estimate glomerular filtration rate in rats. Am. J. Physiol. Renal Physiol. 320, F518–F524 (2021).
Seylaz, J. et al. Dynamic in vivo measurement of erythrocyte velocity and flow in capillaries and of microvessel diameter in the rat brain by confocal laser microscopy. J. Cereb. Blood Flow Metab. 19, 863–870 (1999).
Liebschner, D. et al. Polder maps: improving OMIT maps by excluding bulk solvent. Acta Crystallogr. Struct. Biol. 73, 148–157 (2017).
